Product Description
Nanorab-DSR Cap.
(Rabeprazole 20mg. & Domperidone 20mg. Sustained Release & 10mg. Immediate Release)
Indications -
- Levosulpride - the new prokinetic agent, demonstrates greater central antidopaminergic, antiemetic and antidyspeptic effects
- Reliable Combination with Rabeprazole which starts working immediately and keeps controlling acid reflux 24 hours.
- Well tolerated by patients as compared to domperidone with high safety profile.